10.43

0.29% -0.03

After Hours: 10.56 0.13 +1.25%

Liquidia Corp (LQDA)

Overview News Price History Option Chain Financials Discussions Forecast

Liquidia Corp stock is traded at $10.43, with a volume of 854.73K. It is down -0.29% in the last 24 hours and up +3.99% over the past month. Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Previous Close:

$10.46

Open:

$10.44

24h Volume:

854.73K

Relative Volume:

0.70

Market Cap:

$880.06M

Revenue:

$17.49M

Net Income/Loss:

$-78.50M

P/E Ratio:

-13.55

EPS:

-0.77

Net Cash Flow:

$-52.85M

1W Performance:

-5.53%

1M Performance:

+3.99%

6M Performance:

-18.45%

1Y Performance:

+56.84%

1-Day Range:

$10.17

$10.55

1-Week Range:

$10.17

$11.08

52-Week Range:

$6.06

$16.99

Liquidia Corp Stock (LQDA) Company Profile

Name

Liquidia Corp

Sector

Healthcare (1181)

Industry

Biotechnology (671)

Phone

919.328.4400

Address

419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC

Employee

145

Twitter

@Liquidia_Inc

Next Earnings Date

2024-11-05

Latest SEC Filings

LQDA's Discussions on Twitter

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-19-22	Resumed	Wedbush	Underperform
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform
Jul-22-22	Initiated	Ladenburg Thalmann	Buy
May-31-22	Initiated	BTIG Research	Buy
May-26-22	Initiated	BofA Securities	Buy
Dec-04-20	Initiated	H.C. Wainwright	Buy
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform
Aug-20-18	Initiated	Jefferies	Buy
Aug-20-18	Initiated	Needham	Buy

View All

Liquidia Corp Stock (LQDA) Latest News

04:17 AM

Liquidia (LQDA) to Release Quarterly Earnings on Monday - MarketBeat

04:17 AM

Nov 04, 2024

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024 - Yahoo Finance

Nov 04, 2024

Oct 30, 2024

Liquidia Corp's chief business officer sells shares worth $5,190 - Investing.com India

Oct 30, 2024

Oct 29, 2024

Liquidia Corp's chief business officer sells shares worth $5,190 By Investing.com - Investing.com Canada

Oct 29, 2024

Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Oct 29, 2024

Oct 28, 2024

Analysts Set Liquidia Co. (NASDAQ:LQDA) PT at $24.67 - MarketBeat

Oct 28, 2024

Oct 25, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - PR Newswire

Oct 25, 2024

Oct 16, 2024

Liquidia CEO Roger Jeffs sells $89,450 in stock By Investing.com - Investing.com South Africa

Oct 16, 2024

Liquidia's chief business officer sells $12,729 in stock By Investing.com - Investing.com South Africa

Oct 16, 2024

Liquidia's chief commercial officer sells $16,961 in stock By Investing.com - Investing.com South Africa

Oct 16, 2024

Liquidia's chief business officer sells $12,729 in stock - Investing.com India

Oct 16, 2024

Liquidia's chief commercial officer sells $16,961 in stock - Investing.com India

Oct 16, 2024

Liquidia corp CFO Michael Kaseta sells $43,231 in stock - Investing.com India

Oct 16, 2024

Oct 15, 2024

Liquidia corp CFO Michael Kaseta sells $43,231 in stock By Investing.com - Investing.com Australia

Oct 15, 2024